The study demonstrated a connection between miR-135a and the increased proliferation and invasion of the tumor process, as well as showing that this marker inhibits the apoptosis induced by cisplatin in endometrial cancer cells by regulating the expression of BAX and Bcl-2 [54]. The gene discussed is BCL2; the disease is endometrial cancer.